JOURNAL OF CELLULAR PHYSIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2020-05-29 12418dafm09(暂无昵称)

请问有最近投稿的吗？这个杂志是不是真的超慢了.

96 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2023-06-22 qingzhe1988 来自云南省

各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊

47 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2023-04-04 14618cfam12暂无昵称来自北京

投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2020-04-07 pengpengda

是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表:
你的原始条带是未切割的吗？带有marker吗？

xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？

135 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2020-08-28 123eca1fm35暂无昵称

无论水与不水，投中再说吧。有一篇总比没有强。

116 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2020-04-04 pengpengda

我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表:
请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧

xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2023-01-10 ms7000000037834546 来自湖南省

投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2022-10-18 ms7330898630740957

偏重的研究方向：细胞生物学
经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2023-01-10 ms7000000037834546 来自湖南省

投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=600834, encodeId=17db60083441, content=请问有最近投稿的吗？这个杂志是不是真的超慢了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri May 29 18:21:30 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144267, encodeId=4e87214426e43, content=各位同道，有没有熟悉提交规则的，我已经提交三次，均被打回，一直提示图片上的内容，是否必须通信作者和提交作者都有机构邮箱啊，我（第一作者）的机构邮箱和oricd都提供了，还是不行，有知道的么，跪谢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94554798751, createdName=qingzhe1988, createdTime=Thu Jun 22 18:18:14 CST 2023, time=2023-06-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2123678, encodeId=b91121236e8cf, content=投稿后发现中度预警期刊，立马撤稿，已被课题组拉黑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Tue Apr 04 15:35:07 CST 2023, time=2023-04-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588361, encodeId=f5ba588361a2, content=是的，带marker的xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, beContent=xiaobinyisheng 2020-04-07 00:00:00 发表: 你的原始条带是未切割的吗？带有marker吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Tue Apr 07 00:00:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880475, encodeId=71d18804e59d, content=无论水与不水，投中再说吧。有一篇总比没有强。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5462448298, createdName=123eca1fm35暂无昵称, createdTime=Fri Aug 28 23:04:08 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588159, encodeId=f14f588159d8, content=我前两天收到邮件小修后直接接受，但是要求我提交未剪裁完整条带xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, beContent=xiaobinyisheng 2020-04-03 00:00:00 发表: 请问，最近有人收到杂志社要求提供WB的原始图片的要求吗？我被要求提供未裁剪的包含marker的原始图片？请问是指那种一整张膜敷完所有抗体的图吗？如果是的话，那要求也太高了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/7b5dd2943b07723aa1eba8b77034f6bc.jpg, createdBy=475c2155885, createdName=pengpengda, createdTime=Sat Apr 04 00:00:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109711, encodeId=b2002109e11e5, content=投这个1周了，还是Awaiting Admin Processing，，这是什么情况啊？有人遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:18:30 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2094355, encodeId=db2c2094355c0, content=偏重的研究方向：细胞生物学 经验分享：状态一直是Submitted已经9天了，还没有变化，是不是投错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Tue Oct 18 08:38:52 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109713, encodeId=d7fe2109e138e, content=投稿一周了，一直是Awaiting Admin Processing，这是什么情况啊，有人遇到过吗，求助！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e048497647, createdName=ms7000000037834546, createdTime=Tue Jan 10 19:25:58 CST 2023, time=2023-01-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1227002, encodeId=fa0d122e00267, content=这个还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Fri Jun 17 11:10:27 CST 2022, time=2022-06-17, status=1, ipAttribution=)]

2022-06-17 ugly

这个还能投吗

56 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务